Literature DB >> 21041923

Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.

Guillermo Ruiz-Carrascoso1, Inmaculada Casas, Francisco Pozo, Marta González-Vincent, Pilar Pérez-Breña.   

Abstract

In this study, we report a case of multidrug-resistant influenza A(H3N2) virus isolated from an immunosuppressed patient with prolonged viral shedding. We also describe the genetic characterization of the haemagglutinin, neuraminidase and M2 influenza genes. The virus contained the substitutions E119V in neuraminidase and V27A in M2, which produce resistance to oseltamivir and adamantanes, respectively. This is the first report of this dual mutation pattern in multidrug-resistant influenza A(H3N2) virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041923     DOI: 10.3851/IMP1657

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  5 in total

1.  Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus.

Authors:  Maki Kiso; Tiago J S Lopes; Seiya Yamayoshi; Mutsumi Ito; Makoto Yamashita; Noriko Nakajima; Hideki Hasegawa; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

2.  Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient.

Authors:  Alireza Eshaghi; Sarah Shalhoub; Paul Rosenfeld; Aimin Li; Rachel R Higgins; Peter J Stogios; Alexei Savchenko; Nathalie Bastien; Yan Li; Coleman Rotstein; Jonathan B Gubbay
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

3.  Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection.

Authors:  Matthew B Rogers; Timothy Song; Robert Sebra; Benjamin D Greenbaum; Marie-Eve Hamelin; Adam Fitch; Alan Twaddle; Lijia Cui; Edward C Holmes; Guy Boivin; Elodie Ghedin
Journal:  MBio       Date:  2015-04-07       Impact factor: 7.867

4.  Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.

Authors:  Andrea Pontoriero; Martín Avaro; Estefania Benedetti; Mara Russo; Andrea Czech; Natalia Periolo; Ana Campos; Ana Zamora; Elsa Baumeister
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-11-16       Impact factor: 2.743

5.  Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.

Authors:  Aeron C Hurt; Sook Kwan Leang; Karin Tiedemann; Jeff Butler; Francoise Mechinaud; Anne Kelso; Peter Downie; Ian G Barr
Journal:  Influenza Other Respir Viruses       Date:  2013-03-29       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.